BIOMARIN PHARMACEUTICAL INC

Historical 13F Holders

CUSIP
09061GAK7
All holders as of
Q1 2025
Type
Debt
Class
NOTE 1.250% 5/1
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 68 517 M $559 M
2024 Q4 74 436 M $501 M
2024 Q3 67 429 M $570 M
2024 Q2 62 467 M $626 M
2024 Q1 63 498 M $677 M
2023 Q4 61 478 M $689 M
2023 Q3 52 457 M $699 M
2023 Q2 52 455 M $1.27 B
2023 Q1 47 418 M $635 M
2022 Q4 49 408 M $715 M
2022 Q3 40 342 M $576 M
2022 Q2 37 322 M $559 M
2022 Q1 32 326 M $533 M
2021 Q4 35 220 M $480 M
2021 Q3 28 249 M $469 M
2021 Q2 32 246 M $445 M